Experimental models of regional chemotherapy via the pulmonary artery using cisplatin

G. B. Ratto, M. Esposito, M. Vannozzi, R. A. Fulco, S. Rovida

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The pharmacokinetics of cisplatin was investigated in pigs according to the infusion route and administration modality. Twelve pigs were assigned to receive cisplatin (2.5 mg/kg) via the systemic vein, pulmonary artery, pulmonary artery with stop-flow, and pulmonary artery with stop-flow/outflow occlusion. Serial blood, lung parenchyma and mediastinal node samples were obtained before, at completion of, and 5, 15, 30, 60, 120, 180, and 240 min after infusion. Urine samples were collected 2 h and 2-4 h following drug administration. Specimens from thyroid, esophagus, heart, liver, spleen, adrenal gland, kidney and bone marrow were taken 4 h after treatment. Platinum concentrations in plasma, plasma ultrafiltrate, erythrocytes, tissues and urine were determined by flameless atomic absorption spectroscopy. Pulmonary artery infusion, with or without stop-flow, yielded no significant pharmacokinetic advantage with respect to the systemic vein administration. Instead, pulmonary artery infusion with stop-flow/outflow occlusion produced higher platinum concentrations in lung and mediastinal nodes and lower systemic plasma and tissue platinum levels.

Original languageEnglish
Pages (from-to)222-227
Number of pages6
JournalRegional Cancer Treatment
Volume3
Issue number4
Publication statusPublished - 1990

Fingerprint

Cisplatin
Pulmonary Artery
Theoretical Models
Drug Therapy
Platinum
Veins
Swine
Pharmacokinetics
Urine
Lung
Adrenal Glands
Esophagus
Spectrum Analysis
Thyroid Gland
Spleen
Erythrocytes
Bone Marrow
Kidney
Liver
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology
  • Pharmacology

Cite this

Ratto, G. B., Esposito, M., Vannozzi, M., Fulco, R. A., & Rovida, S. (1990). Experimental models of regional chemotherapy via the pulmonary artery using cisplatin. Regional Cancer Treatment, 3(4), 222-227.

Experimental models of regional chemotherapy via the pulmonary artery using cisplatin. / Ratto, G. B.; Esposito, M.; Vannozzi, M.; Fulco, R. A.; Rovida, S.

In: Regional Cancer Treatment, Vol. 3, No. 4, 1990, p. 222-227.

Research output: Contribution to journalArticle

Ratto, GB, Esposito, M, Vannozzi, M, Fulco, RA & Rovida, S 1990, 'Experimental models of regional chemotherapy via the pulmonary artery using cisplatin', Regional Cancer Treatment, vol. 3, no. 4, pp. 222-227.
Ratto GB, Esposito M, Vannozzi M, Fulco RA, Rovida S. Experimental models of regional chemotherapy via the pulmonary artery using cisplatin. Regional Cancer Treatment. 1990;3(4):222-227.
Ratto, G. B. ; Esposito, M. ; Vannozzi, M. ; Fulco, R. A. ; Rovida, S. / Experimental models of regional chemotherapy via the pulmonary artery using cisplatin. In: Regional Cancer Treatment. 1990 ; Vol. 3, No. 4. pp. 222-227.
@article{875e69d52bed47b9bf0d633dfa72690d,
title = "Experimental models of regional chemotherapy via the pulmonary artery using cisplatin",
abstract = "The pharmacokinetics of cisplatin was investigated in pigs according to the infusion route and administration modality. Twelve pigs were assigned to receive cisplatin (2.5 mg/kg) via the systemic vein, pulmonary artery, pulmonary artery with stop-flow, and pulmonary artery with stop-flow/outflow occlusion. Serial blood, lung parenchyma and mediastinal node samples were obtained before, at completion of, and 5, 15, 30, 60, 120, 180, and 240 min after infusion. Urine samples were collected 2 h and 2-4 h following drug administration. Specimens from thyroid, esophagus, heart, liver, spleen, adrenal gland, kidney and bone marrow were taken 4 h after treatment. Platinum concentrations in plasma, plasma ultrafiltrate, erythrocytes, tissues and urine were determined by flameless atomic absorption spectroscopy. Pulmonary artery infusion, with or without stop-flow, yielded no significant pharmacokinetic advantage with respect to the systemic vein administration. Instead, pulmonary artery infusion with stop-flow/outflow occlusion produced higher platinum concentrations in lung and mediastinal nodes and lower systemic plasma and tissue platinum levels.",
author = "Ratto, {G. B.} and M. Esposito and M. Vannozzi and Fulco, {R. A.} and S. Rovida",
year = "1990",
language = "English",
volume = "3",
pages = "222--227",
journal = "Regional Cancer Treatment",
issn = "0935-0411",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Experimental models of regional chemotherapy via the pulmonary artery using cisplatin

AU - Ratto, G. B.

AU - Esposito, M.

AU - Vannozzi, M.

AU - Fulco, R. A.

AU - Rovida, S.

PY - 1990

Y1 - 1990

N2 - The pharmacokinetics of cisplatin was investigated in pigs according to the infusion route and administration modality. Twelve pigs were assigned to receive cisplatin (2.5 mg/kg) via the systemic vein, pulmonary artery, pulmonary artery with stop-flow, and pulmonary artery with stop-flow/outflow occlusion. Serial blood, lung parenchyma and mediastinal node samples were obtained before, at completion of, and 5, 15, 30, 60, 120, 180, and 240 min after infusion. Urine samples were collected 2 h and 2-4 h following drug administration. Specimens from thyroid, esophagus, heart, liver, spleen, adrenal gland, kidney and bone marrow were taken 4 h after treatment. Platinum concentrations in plasma, plasma ultrafiltrate, erythrocytes, tissues and urine were determined by flameless atomic absorption spectroscopy. Pulmonary artery infusion, with or without stop-flow, yielded no significant pharmacokinetic advantage with respect to the systemic vein administration. Instead, pulmonary artery infusion with stop-flow/outflow occlusion produced higher platinum concentrations in lung and mediastinal nodes and lower systemic plasma and tissue platinum levels.

AB - The pharmacokinetics of cisplatin was investigated in pigs according to the infusion route and administration modality. Twelve pigs were assigned to receive cisplatin (2.5 mg/kg) via the systemic vein, pulmonary artery, pulmonary artery with stop-flow, and pulmonary artery with stop-flow/outflow occlusion. Serial blood, lung parenchyma and mediastinal node samples were obtained before, at completion of, and 5, 15, 30, 60, 120, 180, and 240 min after infusion. Urine samples were collected 2 h and 2-4 h following drug administration. Specimens from thyroid, esophagus, heart, liver, spleen, adrenal gland, kidney and bone marrow were taken 4 h after treatment. Platinum concentrations in plasma, plasma ultrafiltrate, erythrocytes, tissues and urine were determined by flameless atomic absorption spectroscopy. Pulmonary artery infusion, with or without stop-flow, yielded no significant pharmacokinetic advantage with respect to the systemic vein administration. Instead, pulmonary artery infusion with stop-flow/outflow occlusion produced higher platinum concentrations in lung and mediastinal nodes and lower systemic plasma and tissue platinum levels.

UR - http://www.scopus.com/inward/record.url?scp=0025602177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025602177&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0025602177

VL - 3

SP - 222

EP - 227

JO - Regional Cancer Treatment

JF - Regional Cancer Treatment

SN - 0935-0411

IS - 4

ER -